Overview

An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Previous studies using topiramate in Tourette subjects have shown that with the use of this medication subjects report that their tics get better. The purpose of this study is to study if topiramate improves the symptoms of Tourette syndrome, such as motor tics, or other associated symptoms such as attention or obsessive-compulsive problems.
Phase:
Phase 3
Details
Lead Sponsor:
Baylor College of Medicine
Collaborator:
Ortho-McNeil Janssen Scientific Affairs, LLC
Treatments:
Topiramate